TheEdgeResearch
Home / Stocks / BMEZ

BlackRock Health Sciences Term Trust (BMEZ)

NYSE Financial Services Asset Management
$16.81 ▲ +0.06%
Market Cap
$1.70B
Sector
Financial Services
Industry
Asset Management
Beta
0.85
52-Wk Range
13.7-17.25
CEO
John Perlowski
Country
US
Currency
USD

BlackRock Health Sciences Term Trust operates in the Asset Management industry of the Financial Services sector, headquartered in New York, NY, US. The stock last traded at $16.81, up 0.06% on the session, giving a market capitalisation of $1.70B. On trailing twelve-month figures it carries a trailing P/E of 9.50, a net margin of 97.4%. Its beta of 0.85 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
9.50
Price / Sales
70.71
Price / Book
0.29
EV / EBITDA
1836.01
Gross margin
100.0%
Operating margin
3.9%
Net margin
97.4%
Return on equity
—
Debt / equity
0.00
Current ratio
0.00
Dividend yield
7.9%
Payout ratio
153.2%
Company profile
Exchange
New York Stock Exchange
Employees
—
IPO date
2020-01-29
Headquarters
New York, NY, US
About BlackRock Health Sciences Term Trust

BlackRock Health Sciences Term Trust is a closed-end management investment company, which investment objectives are to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The company was founded on August 14, 2019 and is headquartered in Wilmington, DE.

Comparable companies

BlackRock Health Sciences Term Trust is most often compared with the following Financial Services names:

BCATBDJBSTBTTECATFGTRXFZADXSWYEXUSAWX
More research on BMEZ
BMEZ technical analysis BMEZ TheEdge Score Compare against peers
Open full interactive analysis & DCF →